US Patent Issued to BioAlta on May 27 for "Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof" (California, Wyoming Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,311,032, issued on May 27, was assigned to BioAlta Inc. (San Diego).

"Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof" was invented by Jay M. Short (Jackson, Wyo.), Hwai Wen Chang (San Marcos, Calif.) and Gerhard Frey (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "An antibody or antigen-binding antibody fragment having a heavy chain variable region and/or a light chain variable region that specifically binds to Ror2 antigen, as well as immunoconjugates containing the heavy chain variable region and/or the light chain variable region that bind to Ror2 antigen, are provided. Pharmaceutical compositions and kits...